HIV Screening Clinical Guidelines Implementation Guide
0.1.0 - CI Build Unknown region code '840'

HIV Screening Clinical Guidelines Implementation Guide, published by National Association of Community Health Centers, Inc. (NACHC). This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/cqframework/hiv-cds/ and changes regularly. See the Directory of published versions

: Hepatitis C Test Codes - XML Representation

Draft as of 2024-08-12

Raw xml | Download



<ValueSet xmlns="http://hl7.org/fhir">
  <id value="nachc-b2-de103"/>
  <text>
    <status value="extensions"/>
    <div xmlns="http://www.w3.org/1999/xhtml"><p class="res-header-id"><b>Generated Narrative: ValueSet nachc-b2-de103</b></p><a name="nachc-b2-de103"> </a><a name="hcnachc-b2-de103"> </a><a name="nachc-b2-de103-en-US"> </a><p>This value set includes codes based on the following rules:</p><ul><li>Include these codes as defined in <a href="CodeSystem-hiv-custom.html"><code>http://fhir.org/guides/nachc/hiv-cds/CodeSystem/hiv-custom</code></a><table class="none"><tr><td style="white-space:nowrap"><b>Code</b></td><td><b>Display</b></td><td><b>Definition</b></td></tr><tr><td><a href="CodeSystem-hiv-custom.html#hiv-custom-NACHC.46B2.46DE103">NACHC.B2.DE103</a></td><td>Antinuclear antibodies (ANA)</td><td>Hepatitis C Test - Antinuclear antibodies (ANA)</td></tr><tr><td><a href="CodeSystem-hiv-custom.html#hiv-custom-NACHC.46B2.46DE104">NACHC.B2.DE104</a></td><td>Hepatitis C antibody</td><td>Hepatitis C Test - Hepatitis C antibody</td></tr><tr><td><a href="CodeSystem-hiv-custom.html#hiv-custom-NACHC.46B2.46DE105">NACHC.B2.DE105</a></td><td>Hepatitis C antibody; confirmatory test (eg, immunoblot)</td><td>Hepatitis C Test - Hepatitis C antibody; confirmatory test (eg, immunoblot)</td></tr><tr><td><a href="CodeSystem-hiv-custom.html#hiv-custom-NACHC.46B2.46DE106">NACHC.B2.DE106</a></td><td>Infectious agent detection by nucleic acid (DNA or RNA); hepatitis C, direct probe technique</td><td>Hepatitis C Test - Infectious agent detection by nucleic acid (DNA or RNA); hepatitis C, direct probe technique</td></tr><tr><td><a href="CodeSystem-hiv-custom.html#hiv-custom-NACHC.46B2.46DE107">NACHC.B2.DE107</a></td><td>Infectious agent detection by nucleic acid (DNA or RNA); hepatitis C, amplified probe technique, includes reverse transcription when performed</td><td>Hepatitis C Test - Infectious agent detection by nucleic acid (DNA or RNA); hepatitis C, amplified probe technique, includes reverse transcription when performed</td></tr><tr><td><a href="CodeSystem-hiv-custom.html#hiv-custom-NACHC.46B2.46DE108">NACHC.B2.DE108</a></td><td>Infectious agent detection by nucleic acid (DNA or RNA); hepatitis C, quantification, includes reverse transcription when performed</td><td>Hepatitis C Test - Infectious agent detection by nucleic acid (DNA or RNA); hepatitis C, quantification, includes reverse transcription when performed</td></tr><tr><td><a href="CodeSystem-hiv-custom.html#hiv-custom-NACHC.46B2.46DE109">NACHC.B2.DE109</a></td><td>Infectious agent genotype analysis by nucleic acid (DNA or RNA); Hepatitis C virus</td><td>Hepatitis C Test - Infectious agent genotype analysis by nucleic acid (DNA or RNA); Hepatitis C virus</td></tr></table></li><li>Include these codes as defined in <a href="http://terminology.hl7.org/6.0.2/CodeSystem-CPT.html"><code>http://www.ama-assn.org/go/cpt</code></a><table class="none"><tr><td style="white-space:nowrap"><b>Code</b></td><td><b>Display</b></td></tr><tr><td>1014274</td><td>Hepatitis C antibody</td></tr></table></li><li>Include these codes as defined in <code>https://www.cms.gov/Medicare/Coding/HCPCSReleaseCodeSets</code><table class="none"><tr><td style="white-space:nowrap"><b>Code</b></td><td><b>Display</b></td></tr><tr><td>G0472</td><td>Hepatitis c antibody screening, for individual at high risk and other covered indication(s)</td></tr></table></li></ul></div>
  </text>
  <url value="http://fhir.org/guides/nachc/hiv-cds/ValueSet/nachc-b2-de103"/>
  <version value="0.1.0"/>
  <name value="HepatitisCTestCodes"/>
  <title value="Hepatitis C Test Codes"/>
  <status value="draft"/>
  <experimental value="false"/>
  <date value="2024-08-12T19:50:21+00:00"/>
  <publisher
             value="National Association of Community Health Centers, Inc. (NACHC)"/>
  <contact>
    <telecom>
      <system value="url"/>
      <value value="https://www.nachc.org/"/>
    </telecom>
  </contact>
  <description
               value="Codes representing possible values for the Hepatitis C Test element"/>
  <jurisdiction>
    <coding>
      <system value="http://unstats.un.org/unsd/methods/m49/m49.htm"/>
      <code value="840"/>
    </coding>
  </jurisdiction>
  <immutable value="true"/>
  <copyright
             value="Copyright National Association of Community Health Centers, Inc. (NACHC)"/>
  <compose>
    <include>
      <system
              value="http://fhir.org/guides/nachc/hiv-cds/CodeSystem/hiv-custom"/>
      <concept>
        <code value="NACHC.B2.DE103"/>
        <display value="Antinuclear antibodies (ANA)"/>
      </concept>
      <concept>
        <code value="NACHC.B2.DE104"/>
        <display value="Hepatitis C antibody"/>
      </concept>
      <concept>
        <code value="NACHC.B2.DE105"/>
        <display
                 value="Hepatitis C antibody; confirmatory test (eg, immunoblot)"/>
      </concept>
      <concept>
        <code value="NACHC.B2.DE106"/>
        <display
                 value="Infectious agent detection by nucleic acid (DNA or RNA); hepatitis C, direct probe technique"/>
      </concept>
      <concept>
        <code value="NACHC.B2.DE107"/>
        <display
                 value="Infectious agent detection by nucleic acid (DNA or RNA); hepatitis C, amplified probe technique, includes reverse transcription when performed"/>
      </concept>
      <concept>
        <code value="NACHC.B2.DE108"/>
        <display
                 value="Infectious agent detection by nucleic acid (DNA or RNA); hepatitis C, quantification, includes reverse transcription when performed"/>
      </concept>
      <concept>
        <code value="NACHC.B2.DE109"/>
        <display
                 value="Infectious agent genotype analysis by nucleic acid (DNA or RNA); Hepatitis C virus"/>
      </concept>
    </include>
    <include>
      <system value="http://www.ama-assn.org/go/cpt"/>
      <concept>
        <code value="1014274"/>
        <display value="Hepatitis C antibody"/>
      </concept>
    </include>
    <include>
      <system
              value="https://www.cms.gov/Medicare/Coding/HCPCSReleaseCodeSets"/>
      <concept>
        <code value="G0472"/>
        <display
                 value="Hepatitis c antibody screening, for individual at high risk and other covered indication(s)"/>
      </concept>
    </include>
  </compose>
</ValueSet>